Çiğdem Öztürk

12PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 23, 2026
High TROP-2 expression as a predictor of poor neoadjuvant chemotherapy response in luminal B breast cancer: a retrospective clinicopathological study.

|Aug 14, 2025
Tumor budding and Ki-67 proliferation index as biomarkers for NAC response and prognosis in breast cancer.

Oğuzhan Okcu, Çiğdem Öztürk, Bayram Şen

|Aug 14, 2025
Impact of Tumor Budding in Head and Neck Cancers on Neck Lymph Node Metastasis and Prognosis.

Oğuz Gül, Özlem Çelebi Erdivanlı, Mehmet Birinci

|Apr 26, 2025
The Role of Tumor Budding in Early-Stage Laryngeal Cancer Treatment Selection.

Mehmet Birinci, Oğuz Gül, Oğuzhan Okcu

|Apr 02, 2025
Tumor-stroma type and tumor-stroma ratio predict neoadjuvant chemotherapy response in breast cancer.

Oğuzhan Okcu, Çiğdem Öztürk, Anıl Can Yalçın

|Sep 09, 2024
Reporting Hormone Receptor Expression in Breast Carcinomas: Which Method has the Highest Prognostic Power and What Should be the Optimal Cut-off Value?

Çiğdem Öztürk, Oğuzhan Okcu, Seda Duman Öztürk

Pageof 2

Frequent Collaborators

10 joint publications

Oğuzhan Okcu

8 joint publications

Bayram Şen

5 joint publications

Seda Duman Öztürk

4 joint publications

Gökçe Aşkan